Ashok Leyland is the second largest manufacturer of medium and heavy commercial vehicles (M&HCV) in India. It had a 27.0% market share in the domestic M&HCV segment and a marginal presence in the LCV segment (light commercial vehicles). Ashok Leyland... More
Mahindra & Mahindra (M&M) is engaged in the manufacture of UVs, tractors, light commercial vehicles (LCVs) and three-wheelers. While automotive division comprising UVs, LCVs and three-wheelers contributed to 58.5% of FY12 standalone revenues, farm eq... More
ASHOK LEYLAND | M&M | ASHOK LEYLAND/ M&M |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -88.0 | -49.2 | - | View Chart |
P/BV | x | 3.8 | 2.5 | 154.6% | View Chart |
Dividend Yield | % | 2.6 | 0.3 | 893.2% |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ASHOK LEYLAND Mar-19 |
M&M Mar-20 |
ASHOK LEYLAND/ M&M |
5-Yr Chart Click to enlarge
|
||
High | Rs | 168 | 696 | 24.1% | |
Low | Rs | 78 | 246 | 31.6% | |
Sales per share (Unadj.) | Rs | 113.1 | 765.6 | 14.8% | |
Earnings per share (Unadj.) | Rs | 7.5 | -2.6 | -289.5% | |
Cash flow per share (Unadj.) | Rs | 9.8 | 37.4 | 26.1% | |
Dividends per share (Unadj.) | Rs | 3.10 | 2.35 | 131.9% | |
Dividend yield (eoy) | % | 2.5 | 0.5 | 506.6% | |
Book value per share (Unadj.) | Rs | 29.8 | 321.5 | 9.3% | |
Shares outstanding (eoy) | m | 2,935.50 | 1,243.19 | 236.1% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 1.1 | 0.6 | 176.3% | |
Avg P/E ratio | x | 16.4 | -182.3 | -9.0% | |
P/CF ratio (eoy) | x | 12.5 | 12.6 | 99.7% | |
Price / Book Value ratio | x | 4.1 | 1.5 | 281.0% | |
Dividend payout | % | 41.5 | -91.0 | -45.6% | |
Avg Mkt Cap | Rs m | 359,746 | 585,107 | 61.5% | |
No. of employees | `000 | 12.0 | 20.6 | 58.0% | |
Total wages/salary | Rs m | 26,399 | 112,119 | 23.5% | |
Avg. sales/employee | Rs Th | 27,742.6 | 46,118.4 | 60.2% | |
Avg. wages/employee | Rs Th | 2,206.1 | 5,432.6 | 40.6% | |
Avg. net profit/employee | Rs Th | 1,834.0 | -155.5 | -1,179.1% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 331,968 | 951,791 | 34.9% | |
Other income | Rs m | 1,281 | 10,626 | 12.1% | |
Total revenues | Rs m | 333,249 | 962,417 | 34.6% | |
Gross profit | Rs m | 49,100 | 125,643 | 39.1% | |
Depreciation | Rs m | 6,756 | 49,763 | 13.6% | |
Interest | Rs m | 15,022 | 60,647 | 24.8% | |
Profit before tax | Rs m | 28,603 | 25,859 | 110.6% | |
Minority Interest | Rs m | 87 | 0 | - | |
Prior Period Items | Rs m | 0 | 10,426 | 0.0% | |
Extraordinary Inc (Exp) | Rs m | 28 | -19,739 | -0.1% | |
Tax | Rs m | 6,771 | 19,756 | 34.3% | |
Profit after tax | Rs m | 21,946 | -3,210 | -683.7% | |
Gross profit margin | % | 14.8 | 13.2 | 112.0% | |
Effective tax rate | % | 23.7 | 76.4 | 31.0% | |
Net profit margin | % | 6.6 | -0.3 | -1,960.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 164,875 | 640,454 | 25.7% | |
Current liabilities | Rs m | 153,159 | 540,095 | 28.4% | |
Net working cap to sales | % | 3.5 | 10.5 | 33.5% | |
Current ratio | x | 1.1 | 1.2 | 90.8% | |
Inventory Days | Days | 34 | 43 | 79.0% | |
Debtors Days | Days | 30 | 27 | 112.4% | |
Net fixed assets | Rs m | 74,752 | 365,458 | 20.5% | |
Share capital | Rs m | 2,936 | 5,543 | 53.0% | |
"Free" reserves | Rs m | 84,520 | 394,150 | 21.4% | |
Net worth | Rs m | 87,456 | 399,693 | 21.9% | |
Long term debt | Rs m | 130,097 | 522,981 | 24.9% | |
Total assets | Rs m | 391,219 | 1,670,067 | 23.4% | |
Interest coverage | x | 2.9 | 1.4 | 203.6% | |
Debt to equity ratio | x | 1.5 | 1.3 | 113.7% | |
Sales to assets ratio | x | 0.8 | 0.6 | 148.9% | |
Return on assets | % | 9.4 | 3.4 | 274.8% | |
Return on equity | % | 25.1 | -0.8 | -3,124.6% | |
Return on capital | % | 20.1 | 8.4 | 240.3% | |
Exports to sales | % | 4.5 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 14,869 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 15,615 | 22,375 | 69.8% | |
Fx outflow | Rs m | 2,375 | 10,969 | 21.6% | |
Net fx | Rs m | 13,240 | 11,406 | 116.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -37,455 | -14,509 | 258.1% | |
From Investments | Rs m | 18,919 | -69,008 | -27.4% | |
From Financial Activity | Rs m | 23,978 | 69,328 | 34.6% | |
Net Cashflow | Rs m | 5,494 | -13,940 | -39.4% |
Indian Promoters | % | 0.0 | 25.2 | - | |
Foreign collaborators | % | 38.8 | 0.1 | 38,800.0% | |
Indian inst/Mut Fund | % | 12.1 | 15.9 | 75.8% | |
FIIs | % | 20.4 | 36.9 | 55.3% | |
ADR/GDR | % | 12.4 | 5.0 | 248.0% | |
Free float | % | 16.4 | 16.9 | 97.0% | |
Shareholders | 323,610 | 167,076 | 193.7% | ||
Pledged promoter(s) holding | % | 13.1 | 7.7 | 170.6% |
Compare ASHOK LEYLAND With: FORCE MOTORS SML ISUZU TATA MOTORS HMT EICHER MOTOR
Compare ASHOK LEYLAND With: DONGFENG MOTOR (China) SAIC MOTOR (China) HYUNDAI (S. Korea) FORD (US)
Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.
Here's an analysis of the annual report of M&M for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of M&M. Also includes updates on the valuation of M&M.
For the quarter ended June 2020, M&M has posted a net profit of Rs 1 bn (down 95.2% YoY). Sales on the other hand came in at Rs 56 bn (down 56.6% YoY). Read on for a complete analysis of M&M's quarterly results.
For the quarter ended December 2019, ASHOK LEYLAND has posted a net profit of Rs 278 m (down 92.7% YoY). Sales on the other hand came in at Rs 40 bn (down 36.5% YoY). Read on for a complete analysis of ASHOK LEYLAND's quarterly results.
For the quarter ended December 2019, M&M has posted a net profit of Rs 3 bn (down 71.5% YoY). Sales on the other hand came in at Rs 123 bn (down 5.5% YoY). Read on for a complete analysis of M&M's quarterly results.
For the quarter ended September 2019, M&M has posted a net profit of Rs 12 bn (down 26.5% YoY). Sales on the other hand came in at Rs 111 bn (down 14.7% YoY). Read on for a complete analysis of M&M's quarterly results.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.
Our ace stock picker is ready to capitalise on a big growth opportunity.
More